These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34063104)

  • 21. [Recent progress and prospect in oligonucleotide therapeutics].
    Yoshioka K; Kuwahara H; Nishina K; Nagata T; Yokota T
    Nihon Rinsho; 2015 Jun; 73(6):1057-65. PubMed ID: 26065142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential uptake, kinetics and mechanisms of intracellular trafficking of next-generation antisense oligonucleotides across human cancer cell lines.
    Linnane E; Davey P; Zhang P; Puri S; Edbrooke M; Chiarparin E; Revenko AS; Macleod AR; Norman JC; Ross SJ
    Nucleic Acids Res; 2019 May; 47(9):4375-4392. PubMed ID: 30927008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel endosomolytic compounds enable highly potent delivery of antisense oligonucleotides.
    Bost JP; Ojansivu M; Munson MJ; Wesén E; Gallud A; Gupta D; Gustafsson O; Saher O; Rädler J; Higgins SG; Lehto T; Holme MN; Dahlén A; Engkvist O; Strömstedt PE; Andersson S; Edvard Smith CI; Stevens MM; Esbjörner EK; Collén A; El Andaloussi S
    Commun Biol; 2022 Mar; 5(1):185. PubMed ID: 35233031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addressing cancer signal transduction pathways with antisense and siRNA oligonucleotides.
    Juliano RL
    NAR Cancer; 2020 Sep; 2(3):zcaa025. PubMed ID: 33015625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular delivery of oligonucleotide conjugates and dendrimer complexes.
    Juliano RL
    Ann N Y Acad Sci; 2006 Oct; 1082():18-26. PubMed ID: 17145920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid Conjugates Enhance Endosomal Release of Antisense Oligonucleotides Into Cells.
    Wang S; Allen N; Prakash TP; Liang XH; Crooke ST
    Nucleic Acid Ther; 2019 Oct; 29(5):245-255. PubMed ID: 31158063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver as a target for oligonucleotide therapeutics.
    Sehgal A; Vaishnaw A; Fitzgerald K
    J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The nuclear concentration required for antisense oligonucleotide activity in myotonic dystrophy cells.
    van der Bent ML; Paulino da Silva Filho O; Willemse M; Hällbrink M; Wansink DG; Brock R
    FASEB J; 2019 Oct; 33(10):11314-11325. PubMed ID: 31311315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-Functionalized Heteroduplex Antisense Oligonucleotides for Targeted Intracellular Delivery and Gene Silencing in HeLa Cells.
    Sousa de Almeida M; Rothen-Rutishauser B; Mayer M; Taskova M
    Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endosome-disruptive peptides for improving cytosolic delivery of bioactive macromolecules.
    Nakase I; Kobayashi S; Futaki S
    Biopolymers; 2010; 94(6):763-70. PubMed ID: 20564044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oligonucleotide delivery: a cellular prospective.
    Liang E; Ajmani PS; Hughes JA
    Pharmazie; 1999 Aug; 54(8):559-66. PubMed ID: 10483609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent preclinical and clinical advances in oligonucleotide conjugates.
    Craig K; Abrams M; Amiji M
    Expert Opin Drug Deliv; 2018 Jun; 15(6):629-640. PubMed ID: 29727206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Base-modified aptamers obtained by cell-internalization SELEX facilitate cellular uptake of an antisense oligonucleotide.
    Tanaka K; Okuda T; Kasahara Y; Obika S
    Mol Ther Nucleic Acids; 2021 Mar; 23():440-449. PubMed ID: 33473329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breaking down the barriers: siRNA delivery and endosome escape.
    Dominska M; Dykxhoorn DM
    J Cell Sci; 2010 Apr; 123(Pt 8):1183-9. PubMed ID: 20356929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendrimer Conjugates for Light-activated Delivery of Antisense Oligonucleotides.
    Yuan A; Hu Y; Ming X
    RSC Adv; 2015; 5():35195-35200. PubMed ID: 26146545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endosome Escape Strategies for Improving the Efficacy of Oligonucleotide Delivery Systems.
    Wan Y; Moyle PM; Toth I
    Curr Med Chem; 2015; 22(29):3326-46. PubMed ID: 26303176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane Destabilization Induced by Lipid Species Increases Activity of Phosphorothioate-Antisense Oligonucleotides.
    Wang S; Allen N; Liang XH; Crooke ST
    Mol Ther Nucleic Acids; 2018 Dec; 13():686-698. PubMed ID: 30508785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptides for nucleic acid delivery.
    Lehto T; Ezzat K; Wood MJA; El Andaloussi S
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):172-182. PubMed ID: 27349594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re-Engineering RNA Molecules into Therapeutic Agents.
    Egli M; Manoharan M
    Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions.
    Astriab-Fisher A; Sergueev D; Fisher M; Shaw BR; Juliano RL
    Pharm Res; 2002 Jun; 19(6):744-54. PubMed ID: 12134943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.